Article ID Journal Published Year Pages File Type
9005577 Clinical Therapeutics 2005 12 Pages PDF
Abstract
In this study, ciclesonide 160 μg QDwas as effective as budesonide 200 μg BID (400 μg total daily dose) in these adults with persistent asthma. Both treatments were well tolerated.
Keywords
Related Topics
Health Sciences Medicine and Dentistry Medicine and Dentistry (General)
Preview
Comparison of the efficacy of ciclesonide 160 μg QDand budesonide 200 μg BID in adults with persistent asthma: A phase III, randomized, double-dummy, open-label study
Authors
, , , , , , ,